IP Library Granted Patent US 10,406,206
Granted Patent B2
US 10,406,206 · App. 15/413,949 · Granted Sep 10, 2019

Protection against stress-mediated damage from ionizing radiation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,406,206
App. No.
15/413,949
Granted
Sep 10, 2019
Kind
B2
Abstract

The use and screening of modulators of apoptosis is disclosed. The modulators may be, for example, modulator of NF-κB activity. The modulators may be used, for example, in the treatment of NF-κB-mediated diseases, conditions, and injuries.

Claims (4)

1. A method of treating a mammal suffering from stress-mediated damage to normal tissue, the method comprising administering to a subject in need thereof a therapeutically effective amount of composition comprising flagellin, wherein the stress is attributable to whole body radiation.

2. The method of claim 1 wherein the composition is administered prior to, together with, or after the tissue damage.

3. The method of claim 1 , wherein the flagellin is capable of inducing NF-κB activity.

4. The method of claim 3 , wherein the induction of NF-κB is TLR-mediated.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2017
From: GUDKOV, ANDREI V.
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 041107/0742 →